Dr. Sales is a Professor in the Faculty of Nursing, University of Alberta, Canada Research Chair in Interdisciplinary Healthcare Teams, and Chair in Primary Care Research. She has conducted 19 funded research projects, focusing on improving quality of care, knowledge translation and implementation of evidence based best practice, and has over 65 peer-reviewed publications. Her training is in sociology, health economics, econometrics, and general health services research. She is currently conducting two studies of audit with feedback interventions, one in long term care settings, the other in acute hospital and primary care settings.
Dr. Majumdar is an Associate Professor in the Division of General Internal Medicine, Department of Medicine, University of Alberta Medical School. He is also an Adjunct Associate Professor at the University of Alberta School of Public Health and a Visiting Associate Professor at Harvard Medical School. Clinically, he works as a general internist and ward-attending physician at the University Hospital in Edmonton, Alberta.
He obtained his BSc (Honours Biology) in 1988 at the University of Calgary; his MD at the University of Alberta in 1992; and his MPH at the Harvard School of Public Health in 1999. He did his residency/chief residency/fellowship training at the University of Alberta (Internal Medicine, 1992-97) and did a health outcomes and pharmacoepidemiology research fellowship at Harvard Medical School (1997-00).
Since starting on Faculty in 2000, he has obtained almost $30 million dollars in peer-reviewed funding (Principal Investigator [$6 million] or Co-investigator [$23 million]) and has published about 150 peer-reviewed articles in journals such as Annals of Internal Medicine, Archives of Internal Medicine, BMJ, CMAJ, JAMA, Lancet, and New England Journal of Medicine. His work has been recognized at local (Departmental Translational Research Award), national (Young Investigator of the Year, Canadian Society of Internal Medicine), and international (Mack Lipkin Award, Society of General Internal Medicine) levels.
Dr. Majumdar’s research is directed at improving the quality of care for people with chronic conditions such as osteoporosis and type-2 diabetes mellitus. To fulfill this research agenda in the broader field of knowledge translation, his research has followed three inter-related lines of inquiry:
- Does underuse of proven effective treatments exist?
- What are the barriers to, and the facilitators of, best practice? and
- How can we improve practice and optimize use of evidence-based treatments?
Dr. Cummings joined the Faculty of Nursing, University of Alberta in 2004, following 15 years of senior leadership experience in the health care system. Dr. Cummings is principal investigator of the Connecting Leadership Education & Research (CLEAR) Outcomes Program, which focuses on the development of leadership by individuals and organizations to achieve better outcomes for healthcare providers and patients. Dr. Cummings supervises undergraduate and graduate students and teaches in the areas of leadership, policy, knowledge translation and research. She has been the recipient of several awards and achievements among them, the Best Dissertation Award, American Organization of Nurse Executives (2003-2005), 2008 Awards of Excellence in Research from the College and Association of Registered Nurses of Alberta and the Canadian Association of Schools of Nursing, and health investigator awards from the Canadian Institutes for Health Research (New Investigator, 2006-2011) and the Alberta Heritage Foundation for Medical Research (Population Health Investigator, 2006-2012). Dr. Cummings is also President-Elect of the International Society of Nurses in Cancer Care.
Dr. Carole A. Estabrooks is Professor, Faculty of Nursing, at the University of Alberta, Edmonton, Alberta, Canada. She holds a Canada Research Chair in Knowledge Translation and is a fellow in the Canadian Academy of Health Sciences. She leads the Knowledge Utilization Studies Program (KUSP) at the University of Alberta. Dr. Estabrooks’ program of research focuses on knowledge translation in the health sciences; she studies the influence of organizations on the research implementation behaviour of health care providers and the effect of knowledge translation on patient/resident, provider and system outcomes.
She holds a number of active research grants as principal investigator, most recently a five year CIHR funded program of research, Translating Research in Elder Care (TREC), being conducted in long term care facilities in the Canadian Prairie provinces. She is a co-investigator on several additional active grants, among these are a five year CIHR Team Grant in Children’s Pain and a European Union 7th Framework study, Facilitating the Implementation of Research Evidence (FIRE), involving frail older adults living in long term care facilities in five countries.
Dr. Estabrooks is a member of the advisory board for CIHR’s Institute of Aging Advisory Board. She is an Adjunct Professor in Nursing, University of Toronto. She is affiliated with the Nursing Health Services Research Unit, University of Toronto, and a member of two recently funded national teams - the Canadian Dementia Knowledge Translation Network and KT Canada.
Dr. Estabrooks teaches a doctoral level interdisciplinary course in knowledge translation and supervises several postdoctoral fellows and doctoral, masters, and honours undergraduate students studying in the area.
Dr. Fraser’s emerging program of research focuses on decision-making, resource allocation, case management in home care, and related health policy. She currently studies decision-making and resource allocation at all policy levels: macro (government spending), meso (program), and micro (case manager/clinician). Her work focuses on the types of knowledge individuals and groups use to inform policy decisions about home care, home care service delivery, and resource allocation and how various factors influence the way clinicians use knowledge in their everyday practice. In her work, Dr. Fraser uses qualitative methods including, ethnographic methods, ethnoscience, grounded theory, and constant comparison. Dr. Fraser is presently engaged in an innovative research study using arts-based research methods to uncover and disseminate knowledge about the nature of home care.
Dr. Lisa Hartling is Director of the Alberta Research Center for Health Evidence and Director of the University of Alberta Evidence-based Practice Center. She has been involved in conducting systematic reviews and methodological research around issues in systematic reviews for the last 10 years, and has published extensively in this area. She is a systematic reviewer with seven Cochrane Review Groups and is a member of the Cochrane Bias Methods Group. She is also Co-Coordinator of the Cochrane Child Health Field. She is actively involved in a new international initiative called StaR Child Health whose mission is to improve the design, conduct and reporting of randomized trials to ensure a valid and relevant evidence base for decision making in child health. Her interests include: risk of bias in randomized controlled trials and its impact on evidence synthesis; methods for assessing methodological quality in non-randomised studies; methods for assessing quality of evidence; other forms of evidence synthesis including overviews of reviews and mixed treatment comparisons.
Dr. Johnson holds a Canada Research Chair in Diabetes Health Outcomes and a Senior Health Scholar award from the Alberta Heritage Foundation for Medical Research. He chairs the Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD). Dr. Johnson is interested the assessment of the quality of health care delivery on health outcomes in diabetes, including pharmacoepidemiologic studies, assessing health-related quality of life and economic outcomes, and in the evaluation of policies and alternative care delivery strategies to improve the efficiency and quality of care in diabetes.
Dr. Johnson is a pharmacist and health outcomes researcher. He received a B.S.P. with Distinction in 1988 and a M.Sc. in clinical pharmacy/pharmacoepidemiology in 1994, both from the University of Saskatchewan. Dr. Johnson received his Ph.D. in Pharmaceutical Sciences from The University of Arizona in 1996, majoring in pharmaceutical economics. Dr. Johnson is a Fellow with the Institute of Health Economics in Edmonton, and holds adjunct appointments in the Faculties of Medicine and Pharmacy & Pharmaceutical Sciences, University of Alberta and the College of Pharmacy, University of Arizona.
Terry Klassen is Director of Alberta Research Centre for Health Evidence (ARCHE) and Professor in the Department of Pediatrics at the University of Alberta and Stollery Children’s Hospital. He served as Chair of this Department from 1999 to 2009. He is a clinician scientist whose clinical base is Pediatric Emergency Medicine and has been active in Pediatric Emergency Research of Canada collaborating on a national research program involving randomized controlled trials, systematic reviews and knowledge translation. He is the leader of the Cochrane Child Health Field and co-Editor in Chief of the Evidence-Based Child Health.
Professor, Division of General Internal Medicine, Faculty of Medicine and Dentistry, University of Alberta
Dr. McAlister is a general internist and a Health Scholar of the Alberta Heritage Foundation for Medical Research who holds the Aventis/Merck Frosst Chair in Patient Health Management at the University of Alberta. Dr. McAlister obtained his MD at the University of Alberta in 1990 and completed his general internal medicine residency in 1994. He completed his MSc in Epidemiology from the University of Ottawa in 1998 and did post-doctoral training at the Centre for Evidence-Based Medicine, Oxford University, UK. Dr. McAlister’s main research thrust is in evidence-based medicine and the optimization of patient outcomes in hypertension, heart failure, perioperative care, and coronary artery disease. He attends on the general medicine CTU, has published 216 peer-reviewed manuscripts, and has received the Canadian Society of Internal Medicine Young Investigator Award (1999) and the Royal College of Physicians and Surgeons of Canada Gold Medal for Research (2005). He has been involved with the Canadian Hypertension Education Program (CHEP) since its inception in 1999 - he chaired the Central Review Committee for several years and currently chairs the Outcomes Research Task Force investigating the impact of the CHEP Recommendations and evaluating other strategies to improve the care of patients with hypertension and/or atherosclerotic disease. He is currently President-Elect of the Canadian Society of Internal Medicine and also serves on the Advisory Board of the Canadian Cochrane Network. He has conducted several randomized trials testing different knowledge translation strategies in vascular disease.
Dr. Rowe is a Professor in the Department of Emergency Medicine, University of Alberta. He trained in Clinical Epidemiology at McMaster University and his interests include systematic reviews, clinical trials, and airway diseases. He has held the Canada Research Chair in Emergency Airway Diseases since 2001. Since 2002, he has Co-Directed the Evidence-Based Practice Centre at the University of Alberta; he has been a Co-Editor of the Cochrane Airways Group since 1995 and is on the Advisory Committee of the Prehospital and Emergency Health Care Field (2004). He is a Senior Associate Editor of the Canadian Journal of Emergency Medicine (CJEM) and was a Consulting Editor for the Annals of Emergency Medicine from 1998-2008. He is the recipient of a number of teaching/mentorship awards and has published more than 275 peer-reviewed manuscripts and 20 book chapters. He is the lead Editor of Evidence Based Emergency Medicine a textbook published in 2009 by BMJ-Wiley-Blackwell Publishers.
My emerging research program, ECHO (translating Evidence in Child Health to improve Outcomes), focuses on knowledge translation in pediatric health settings to improve outcomes for children, their families, and the health care system. The goal of knowledge translation activities is to increase the use of relevant knowledge, commonly research, among clinicians, managers, administrators, and policy makers. Knowledge translation problems are complex because they involve behavior change among providers working in complex and high velocity health care organizations. In my research program, I explore the reasons why research is used or not and what facilitates and hinders this process, with a particular focus on elements of the context or work environment.
Over the past few years, Dr. Simpson has actively participated in a number of health services research studies that measure the financial burden of diabetes and its complications. He has also participated in a number of pharmacoepidemiological studies evaluating the impact of drug therapy on health outcomes in diabetes. Dr. Simpson’s research interests include measuring the impact of medication adherence on health outcomes, identifying patient-perceived barriers to medication use, and optimizing the use of drug therapy for diabetes and cardiovascular disease.
My program of research focuses on knowledge translation to improve the health outcomes for frail older adults, their families and the health care system. This builds on my clinical practice and research which has consistently centred on the maintaining, enhancing, or measuring the functional abilities (activities of daily living) of the oldest old. I have worked in acute care, rehabilitation, and most recently in long-term care settings. My AHFMR-funded doctoral research in the Department of Community Health Sciences, Faculty of Medicine, at the University of Calgary focused on functional transitions in walking and eating ability by identifying the incidence and predictors of excess disability in residents with dementia living in long-term care facilities. In my CIHR and AHFMR-funded post-doctoral research in the Faculty of Nursing, at the University of Alberta I assessed the effectiveness of various knowledge translation interventions to introduce a simple mobility innovation into the daily practice of healthcare aides. The goal of this MOVE (Mobility of Vulnerable Elders) study was to maintain the mobility of long-term care residents with dementia. Currently I am studying the contextual and environmental factors that influence the uptake of simple innovations intended to enhance the well-being of frail older adults, with particular attention to the sustainability of such innovations.
Dr. Ross Tsuyuki was born and raised in Vancouver, B.C. Canada. His training includes:
- B.Sc.(Pharm.) from the University of British Columbia
- Residency at St. Paul’s Hospital, Vancouver.
- Doctor of Pharmacy (Pharm.D.) from the State University of New York at Buffalo
- Postdoctoral fellowship in the Division of Cardiology at McMaster University, Hamilton, Ontario
- MSc in Health Research Methods from McMaster University
Past positions include:
- Staff Pharmacist, St. Paul’s Hospital, Vancouver
- Assistant Professor, Faculty of Pharmaceutical Sciences, University of British Columbia
- Clinical pharmacist in the Coronary Care Unit at the Royal Columbian Hospital, New Westminster, B.C.
- Dr. Tsuyuki is currently a Professor of Medicine (Cardiology) and the Director of the Epidemiology Coordinating and Research (EPICORE) Centre, a health research coordinating centre, and the Centre for Community Pharmacy Research and Interdisciplinary Strategies (COMPRIS).
He is also a Professor in the Faculty of Pharmacy and Pharmaceutical Sciences and an Adjunct Professor in the School of Public Health at the University of Alberta and an Honorary Professor in the School of Pharmacy at the University of Auckland.
Dr. Tsuyuki has received several awards for teaching, as well as appointment as a Fellow of the Canadian Society of Hospital Pharmacists and the American College of Cardiology. In 2005 he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association.
His interests include: improving the care of patients with heart failure and hypertension, prevention of cardiovascular disease, pharmacy practice research, provision of support for other researchers and training the next generation of health researchers.